Australia's Alcidion Group rises on A$7.5 million three-year contract

By Reuters News

** Shares of Alcidion Group ALC.AX rise as much as 4.8% to A$0.110, their highest level since June 5

** Stock logs its biggest intraday pct gain since September 24

** Stock on track for its best month since November 2025, if gains hold

** The healthcare technology inks expanded contract with Northern Care Alliance NHS Foundation Trust to upgrade existing software that tracks patient movement and hospital beds data at the Salford Royal Hospital with ALC's Miya Flow software

** Total contract valued at A$7.5 million ($5.22 million) over an initial three-year term with options to extend for an additional two years

** Alcidion says annual revenue expected to be recognised is about A$4.5 million

** YTD, stock up 4.8%


($1 = 1.4360 Australian dollars)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.